Open access
Open access
Powered by Google Translator Translator

General Gynecology

CDC releases new guidelines for the treatment of sexually transmitted infections.

23 Jul, 2021 | 10:41h | UTC

Table of Contents: Sexually Transmitted Infections Treatment Guidelines, 2021

Guideline: Sexually Transmitted Infections Treatment Guidelines, 2021 – Centers for Disease Control and Prevention

Related (just released): WHO Guidelines for the management of symptomatic sexually transmitted infections.

 

Commentary on Twitter (thread – click for more)

 


WHO Guidelines for the management of symptomatic sexually transmitted infections.

22 Jul, 2021 | 10:54h | UTC

Guidelines for the management of symptomatic sexually transmitted infections – World Health Organization

News release: Launch WHO guidelines for the management of symptomatic sexually transmitted infection – World Health Organization

 

Commentary on Twitter

 


Review: Diagnosis, evaluation, and treatment of adenomyosis.

14 Jul, 2021 | 11:01h | UTC

Diagnosis, Evaluation, and Treatment of Adenomyosis – JAMA (free for a limited period)

 


Podcast | Heavy menstrual bleeding, anticoagulation & coagulopathy in menstruating patients.

9 Jul, 2021 | 09:56h | UTC

#280 Heavy Menstrual Bleeding, Anticoagulation & Coagulopathy in Menstruating Patients – The Curbsiders

 


Clinical guidelines for female lower urinary tract symptoms.

8 Jul, 2021 | 08:44h | UTC

Clinical Guidelines for Female Lower Urinary Tract Symptoms – International Journal of Urology

 


New WHO recommendations for screening to prevent cervical cancer – the new guideline recommends an HPV DNA based test every 5 years as the preferred method, rather than visual inspection with acetic acid (VIA) or cytology (Pap smear).

7 Jul, 2021 | 08:51h | UTC

News release: New recommendations for screening and treatment to prevent cervical cancer – World Health Organization

See guidance: WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention – World Health Organization

 

Commentary on Twitter (thread – click for more)

 


Putting people first in managing their health: new WHO guideline on self-care interventions – “Whether it’s for their experience of pregnancy and childbirth; managing fertility intentions, preventing sexually transmitted infections; enjoying better sexual health of themselves or their partner, or self-monitoring their blood pressure, access to quality self-care interventions can help meet people’s many health needs and rights”.

28 Jun, 2021 | 09:40h | UTC

News release: Putting people first in managing their health: new WHO guideline on self-care interventions – World Health Organization

See guidance: WHO consolidated guideline on self-care interventions for health

 

Commentary on Twitter (thread – click for more)

 


Guideline | Perimenopause and Postmenopause – Diagnosis and Interventions.

28 Jun, 2021 | 09:32h | UTC

Perimenopause and Postmenopause – Diagnosis and Interventions. Guideline of the DGGG and OEGGG (S3-Level, AWMF Registry Number 015-062, September 2020) – Geburtshilfe Frauenheilkd

 


Review: chronic pelvic pain in women.

17 Jun, 2021 | 09:36h | UTC

Chronic Pelvic Pain in Women: A Review – JAMA (free for a limited period)

Audio clinical review: Diagnosis and Clinical Care of Women With Chronic Pelvic Pain

 


Pessaries for pelvic organ prolapse – looking at the Cochrane evidence.

24 May, 2021 | 08:17h | UTC

Pessaries for pelvic organ prolapse – looking at the Cochrane evidence – Evidently Cochrane

Original Review: Pessaries (mechanical devices) for managing pelvic organ prolapse in women – Cochrane Library

 


#ACC21 – The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 – “The Lancet women and cardiovascular disease Commission outlines 10 ambitious recommendations to improve health outcomes for millions of women”.

18 May, 2021 | 07:32h | UTC

Homepage: The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 – The Lancet (free registration required)

Infographic: Women and cardiovascular disease

Video: The Lancet women and cardiovascular disease Commission

News release: Experts call for urgent action to reduce global burden of cardiovascular disease in women by 2030 – The Lancet

 

Commentary on Twitter (thread – click for more)

 


Large trial with over 200.000 patients finds ovarian cancer screening does not reduce deaths.

14 May, 2021 | 08:32h | UTC

Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial – The Lancet

Commentaries: Screening for ovarian cancer did not reduce early deaths – Imperial College London AND Annual screening for ovarian cancer does not save lives, study finds – The Guardian

 


RCT: Community pharmacies provision of a progestogen-only pill + invitation to a sexual and reproductive health clinic as a bridging contraception intervention for women receiving emergency contraception is associated with increased subsequent use of long-term effective contraception.

10 May, 2021 | 00:45h | UTC

Provision of the progestogen-only pill by community pharmacies as bridging contraception for women receiving emergency contraception: the Bridge-it RCT – Health Technology Assessment

 


Study: Despite clinical practice guidelines recommending cervical cancer screening every 3 years or cotesting with HPV and cytologic testing every 5 years, many women get tested much more often

3 May, 2021 | 05:19h | UTC

Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014 – JAMA Network Open

 


AHA Scientific Statement: Close monitoring for heart risk needed if breast, prostate cancer treatment includes hormonal therapies

29 Apr, 2021 | 08:33h | UTC

Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association – Circulation: Genomic and Precision Medicine

News release: Close monitoring for heart risk needed if breast, prostate cancer treatment includes hormones – American Heart Association

Top Things to Know: Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System – American Heart Association

Commentaries: Hormonal Therapy for Breast and Prostate Cancer: Lessons and Opportunities – American Heart Association AND Hormonal Based Therapies in the Treatment of Breast and Prostate Cancer – balancing the risks! – American Heart Association AND Hormone Cancer Therapies Increase CV Risk: AHA Scientific Statement – TCTMD AND Closely Monitor Heart Health in Cancer Patients Who Get Hormonal Therapies: AHA – HealthDay

 


M-A: Lidocaine lubricant jelly does not reduce pain perception during female urethral catheterization

27 Apr, 2021 | 09:11h | UTC

Lidocaine lubricant jelly does not reduce pain perception during female urethral catheterization: A systematic review with meta‐analysis and trial sequential analysis – The International Journal of Clinical Practice (link to abstract – $ for full-text)

 


RCT: No benefit from immune checkpoint inhibitors in newly diagnosed stage III or IV ovarian cancer

25 Apr, 2021 | 20:57h | UTC

Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39) – Journal of Clinical Oncology

Editorial: Immune Checkpoint Inhibitors in Ovarian Cancer: Can We Bridge the Gap Between IMagynation and Reality?

 


Guideline: Prevention of Positioning Injuries During Gynecologic Surgery

25 Apr, 2021 | 20:50h | UTC

The Prevention of Positioning Injuries During Gynecologic Surgery. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/077, October 2020) – Geburtshilfe und Frauenheilkunde

 


Guideline: Diagnosis and Treatment of Endometriosis

25 Apr, 2021 | 20:46h | UTC

Diagnosis and Treatment of Endometriosis. Guideline of the DGGG, SGGG and OEGGG (S2k Level, AWMF Registry Number 015/045, August 2020) – Geburtshilfe und Frauenheilkunde

 


Guideline: Vulvovaginal Candidosis (Excluding Mucocutaneous Candidosis)

25 Apr, 2021 | 20:47h | UTC

Vulvovaginal Candidosis (Excluding Mucocutaneous Candidosis): Guideline of the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry Number 015/072, September 2020) – Geburtshilfe und Frauenheilkunde

 


RCT: Treatments for vulnerable older adult women with ovarian cancer compared

23 Apr, 2021 | 08:15h | UTC

Efficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer: A Randomized Clinical Trial – JAMA Oncology (free for a limited period)

Editorial: Vulnerable Older Adults With Ovarian Cancer—Time to Stop Undertreating (free for a limited period)

 


Chlamydia and gonorrhea: new recommendation to screen sexually active patients under 30

20 Apr, 2021 | 05:42h | UTC

Guideline: Recommendation on screening for chlamydia and gonorrhea in primary care for individuals not known to be at high risk – Canadian Medical Association Journal

News release: Under 30 and sexually active? It’s a good idea to get tested for chlamydia and gonorrhea – Canadian Task Force on Preventive Health Care

Summary: Chlamydia and gonorrhea: new recommendation to screen sexually active patients under 30 – Canadian Task Force on Preventive Health Care

Related USPSTF Draft Statement: Screening for Chlamydia and Gonorrhea – U.S. Preventive Services Task Force

 


AHA Scientific Statement | Adverse Pregnancy Outcomes and Cardiovascular Disease Risk

30 Mar, 2021 | 03:08h | UTC

Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association – Circulation

News Release: Six pregnancy complications are among red flags for heart disease later in life – American Heart Association

 


Covid-19: Middle aged women face greater risk of debilitating long term symptoms

28 Mar, 2021 | 22:49h | UTC

Covid-19: Middle aged women face greater risk of debilitating long term symptoms – The BMJ

Linked Opinion: The stigma is real for people living with long covid – The BMJ Opinion

 


Special Issue: The importance of women’s health in peri‐operative care

16 Mar, 2021 | 01:42h | UTC

Special Issue: The importance of women’s health in peri‐operative care – Anaesthesia

 


Stay Updated in Your Specialty

No spam, just news.